Dr. Jonathan Gutman, MD
Claim this profileUniversity of Colorado Hospital
Studies Cancer
Studies Hematological Malignancies
7 reported clinical trials
9 drugs studied
Area of expertise
1Cancer
Stage IV
Stage I
Stage II
2Hematological Malignancies
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Jonathan Gutman, MD is currently running
Shingrix Vaccine
for Bone Marrow Transplant Recipients
This research is designed to determine if the adjuvanted recombinant glycoprotein E (gE) herpes zoster (HZ) vaccine (Shingrix) has acceptable immunogenicity and safety in people who have undergone allogeneic stem cell transplant (allo-SCT). Specifically, it will determine the effect of the interval after transplantation on the immune response and if an additional dose of vaccine is needed to improve the vaccine-induced responses.
Recruiting1 award Phase 29 criteria
CAR T Cell Therapy
for Non-Hodgkin's Lymphoma
This open-label, single arm phase 1/1b trial aims to determine the safety and tolerability of anti-CD19 and anti-CD22 chimeric antigen receptor-expressing (CAR) T cells (CD19x22 CAR T) in adolescents and adults with relapsed/refractory (R/R) B-cell Non-Hodgkin Lymphoma (B-NHL). Phase 1 will determine the maximum tolerated dose of CD19x22 CAR T cells using a standard 3+3 trial design. Phase 1b is an expansion phase designed to evaluate the preliminary efficacy of CD19x22 CAR T in CAR-treated and CAR-naïve patients.
Recruiting1 award Phase 1
More about Jonathan Gutman, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Jonathan Gutman, MD has experience with
- Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant
- Miltenyi CliniMACS® CD34 Reagent System
- CD19x22 CAR T Cells
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
- Unlicensed CBU
- Unlicensed Cryopreserved Cord Blood Units
Breakdown of trials Jonathan Gutman, MD has run
Cancer
Hematological Malignancies
Acute Myeloid Leukemia
Blood Diseases
Blood Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Gutman, MD specialize in?
Jonathan Gutman, MD focuses on Cancer and Hematological Malignancies. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage I.
Is Jonathan Gutman, MD currently recruiting for clinical trials?
Yes, Jonathan Gutman, MD is currently recruiting for 4 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Gutman, MD has studied deeply?
Yes, Jonathan Gutman, MD has studied treatments such as Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant, Miltenyi CliniMACS® CD34 Reagent System, CD19x22 CAR T Cells.
What is the best way to schedule an appointment with Jonathan Gutman, MD?
Apply for one of the trials that Jonathan Gutman, MD is conducting.
What is the office address of Jonathan Gutman, MD?
The office of Jonathan Gutman, MD is located at: University of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.